SEQUENT Theses are swing ideas which you can add your watchlist and analysis for yourself !
Keep on your radar!
I am not sebi ragister
−5.15INR
−1.21 BINR
14.19 BINR
117.73 M
About SEQUENT SCIENTIFIC
Sector
CEO
Rajaram Narayanan
Headquarters
Mumbai
Website
Employees (FY)
1.39 K
Founded
1985
ISIN
INE807F01027
FIGI
BBG000BHLRM2
SeQuent Scientific Ltd. engages in the manufacturing and development of veterinary pharmaceuticals and specialty chemicals. It operates through the following geographical segments: Europe, Asia, and Rest of the World. The company was founded on June 28, 1985 and is headquartered in Mumbai, India.
Bearish STOCKA complete bearish cup formation on this pharma stock. The stock now stands on a very crucial point, the support level around (160-185). It may take a turn after the huge fall and consolidate around these levels for sometime. RSI is also below 40.
SEQUENT- Analysis
Entry above 141 or 150
Expected Major targets - 172 or 178 if sustain above this then 206 then 221 then hold.
Minor Targets - 159 and 199
Stop loss - closing below 135 and strictly 120
Please do your due diligence before trading or investment.
*Comment or message me if you wish to see my
Sequent Scientific - Buy Opportunity & HoldAs per previouse chart history and technical analysis of this stock, it indicates to buy at 140.60 and hold for long run and wait for retest of previouse level between 126-110 and after reversal from this point, you can buy for a good profit.
Do your own research before entering into the market.
I
SEQUENT !! GOOD TREND CHANGE1) CONSOLIDATION
2) BREAKOUT WITH VOLUME
3) CONSOLIDAITON
Best way stock is going up with all time high volumes
sequentDown trend ended by price action lower low formation ended. Break out with gud volume. 200 MA will be hurdle. Target will be huge.
Buy on some retracement
sl 90
it has gud potential for upside . Follow strict SL & Proper RISK REWARD RATIO. This is the only holy grail in the market.
ROUNDING BOTTOM PATTERN UNDER PROGRESS ON SEQUENT SCIENTIFICERounding bottom under progress on SEQUENT SCIENTIFICE monthly chart. Brake out level @ 128. if price sustain above 128, position can be initiated for target price of 230. stop loss is (-10 point)
Buy sequent at 90-95Sequent 3 months very tight closing around 90-95.
Time to buy some quantity for moderate risk takers.
Target 600 till end of 2026 or before
Sequent Bull Move Continuous Sequent is performance based stock. It gave a breakout earlier and now after a nice consolidation it seems to move again in bullish direction.
Reasons :
Taking support at 200 EMA and VWAP.
moving in Higher HIGH Higher LOW.
Important level are marked in the chart.
RSI breaking 50 to upsid
Sequent Scientific Breakout Short termMonthly is reversing from major support zone, previous low. Bottom fishing.
Weekly is into an uptrend, RSI is perfectly moving from over sold to strength zone of 70+
Daily broke out of consolidation zone, flag anf pole pattern.
One can look for trade as per the supply zones marked.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SEQUENT is 119.50 INR — it has increased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SEQUENT SCIENTIFIC stocks are traded under the ticker SEQUENT.
SEQUENT SCIENTIFIC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SEQUENT stock is 4.76% volatile and has beta coefficient of −0.27. Check out the list of the most volatile stocks — is SEQUENT SCIENTIFIC there?
SEQUENT earnings for the last quarter are 0.70 INR per share, whereas the estimation was 0.70 INR resulting in a 0% surprise. The estimated earnings for the next quarter are 0.40 INR per share. See more details about SEQUENT SCIENTIFIC earnings.
SEQUENT SCIENTIFIC revenue for the last quarter amounts to 3.38 B INR despite the estimated figure of 3.38 B INR. In the next quarter revenue is expected to reach 3.75 B INR.
Yes, you can track SEQUENT SCIENTIFIC financials in yearly and quarterly reports right on TradingView.
SEQUENT stock has fallen by 3.36% compared to the previous week, the month change is a 3.60% rise, over the last year SEQUENT SCIENTIFIC has showed a 51.75% increase.
SEQUENT net income for the last quarter is 82.68 M INR, while the quarter before that showed −83.80 M INR of net income which accounts for 198.66% change. Track more SEQUENT SCIENTIFIC financial stats to get the full picture.
Today SEQUENT SCIENTIFIC has the market capitalization of 29.78 B, it has increased by 1.58% over the last week.
Like other stocks, SEQUENT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SEQUENT SCIENTIFIC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.39 K employees. See our rating of the largest employees — is SEQUENT SCIENTIFIC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SEQUENT SCIENTIFIC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SEQUENT SCIENTIFIC stock shows the buy signal. See more of SEQUENT SCIENTIFIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SEQUENT SCIENTIFIC EBITDA is 372.00 M INR, and current EBITDA margin is 3.24%. See more stats in SEQUENT SCIENTIFIC financial statements.